Toxicologic methods: Controlled human exposures

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 4, 2000, Pages 605-613

  Utell, M J ^a   Frampton, M W ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Air pollution; Asthma; Cardiac; Chronic obstructive pulmonary disease; Experimental design; Exposure; Gases human; Inflammation; Methods; Particles; Pulmonary function; Respiratory

Indexed keywords

CARBON MONOXIDE; NITROGEN DIOXIDE; OZONE; SULFUR DIOXIDE; TOBACCO SMOKE;

AIR POLLUTANT; AIR POLLUTION; AMBIENT AIR; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL STUDY; COMBUSTION; CONTROLLED STUDY; DIESEL ENGINE; ENVIRONMENTAL EXPOSURE; EXHAUST GAS; EXPERIMENTAL MODEL; HUMAN; MACHINE; METHODOLOGY; PRIORITY JOURNAL; TOXICITY;

ANIMALIA; NICOTIANA TABACUM;

EID: 0033828334     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s4605     Document Type: Article

References (108)

1. Quantitative clinical studies with defined exposure atmospheres
2. Biological deposition of airborne particles: Basic principles and application to vehicular emissions
3. Statistical considerations in designing, analyzing, and reporting of clinical pulmonary studies
4. Clinical studies of airborne pollutants
5. Spirometry and flow-volume curves
6. Standardization of spirometry: 1994 update
7. Lung function testing: Selection of reference values and interpretation strategies
8. Variability of routine pulmonary function tests
9. Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma
10. Physiological measurements providing enhanced sensitivity in detecting early effects of inhalants
11. Ozone exposure in humans: Inflammatory, small and peripheral airway responses
12. Inhalation of 0.30 ppm nitrogen dioxide potentiates exercise-induced bronchospasm in asthmatics
13. Airway reactivity to sulfate and sulfuric acid aerosols in normal and asthmatic subjects
14. Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans
15. Airway responses to sulfate and sulfuric acid aerosols in asthmatics: An exposure-response relationship
16. Ozone responsiveness in smokers and nonsmokers
17. Investigative use of bronchoscopy in asthma
18. 3-induced change in bronchial reactivity to methacholine and airway inflammation in humans
19. Airway inflammation in smokers and nonsmokers with varying responsiveness to ozone
20. Ozone exposure increases aldehydes in human lung epithelial lining fluid
21. Ozone-induced inflammation is attenuated with multiday exposure
22. Greater ozone-induced inflammatory responses in subjects with asthma
23. Nitrogen dioxide exposure in vivo and human alveolar macrophage inactivation of influenza virus in vitro
24. Effects of nitrogen dioxide exposure on human host defense
25. Persistent airway inflammation but accommodated antioxidant and lung function responses after repeated daily exposure to nitrogen dioxide
26. Cell response in bronchoalveolar lavage fluid after exposure to sulfur dioxide: A time-response study
27. Sulfuric acid aerosol exposure in humans assessed by bronchoalveolar lavage
28. Composition of human airway mucins and effects after inhalation of acid aerosol
29. Effects of inhaled sulfuric acid aerosols on pulmonary immunocompetence: A comparative study in humans and animals
30. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers
31. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease
32. Mononuclear cells from human lung parenchyma support antigen-induced T lymphocyte proliferation
33. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples
34. A technique for isolated airway segment lavage
35. 1 and FVC do not correlate with measures of inflammation
36. Disruption of normal iron homeostasis after bronchial instillation of an iron-containing particle
37. Part III: Mediators of inflammation in bronchoalveolar lavage fluid from nonsmokers, and smokers, and asthmatic subjects exposed to ozone: A collaborative study
38. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma
39. Sputum measurements to assess airway inflammation in asthma
40. Cellular and biochemical analysis of induced sputum from asthamatic and from healthy subjects
41. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses
42. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
43. Use of induced sputum cell counts to investigate airway inflammation in asthma
44. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects
45. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects
46. Changes in sputum composition between two inductions performed on consecutive days
47. Effect of repeated sputum induction on cell counts in normal volunteers
48. Spontaneous and induced sputum to measure indices of airway inflammation in asthma
49. Analysis of induced sputum after air and ozone exposures in healthy subjects
50. 2 exposure on induced sputum in normal, asthmatic and COPD subjects
51. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients
52. Increased carbon monoxide in exhaled air of asthmatic patients
53. Breath isoprene: Temporal changes in respiratory output after exposure to ozone
54. Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical mediated lipid peroxidation: A case study
55. Effect of cigarette smoking on pentane excretion in alveolar breath
56. Measured breath
57. Exhaled nitric oxide: A new lung function test
58. Increased amount of nitric oxide in exhaled air of asthmatics
59. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract
60. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma
61. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation
62. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients
63. Exhaled pentane and nitric oxide levels are increased following exposure to 0.25 ppm ozone in healthy individuals
64. Determination of production of nitric oxide by the lower airways of humans-theory
65. Effects of exposure to 4 ppm nitrogen dioxide in healthy and asthmatic volunteers
66. 2 exposure in healthy older adults
67. Cardiovascular effects of ozone exposure in human volunteers
68. Oxygen saturation, pulse rate, and particulate air pollution
69. Cardiac arrhythmia induction after exposure to residual oil fly ash particles in a rodent model of pulmonary hypertension
70. Particular air pollution and acute health effects
71. Session 5: Who is susceptible to particulate matter and why?
72. Merchanisms of morbidity and mortality from exposure to ambient air particles
73. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
74. RR variability in healthy, middle-age persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction
75. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease
76. Dispersion of repolarization: A noninvasive marker of nonuniform recovery of ventricular excitability
77. Electrical alternans and vulnerability to ventricular arrhythmias
78. Impact of reduced heart rate variability on risk of cardiac events
79. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD
80. Abnormal myocardial repolarization in response to hypoxaemia and fenoterol
81. Physiologically based approaches for examining the pharmacokinetics of inhaled vapors
82. Pharmacokinetics of inhaled styrene in human volunteers
83. Quantitative exposure of humans to an octametylcyclote-trasiloxane (D4) vapor
84. 14C-octamethylcyclote-trasiloxane (D4) following nose-only vapor inhalation exposure in the rat
85. Disposition and metabolism of octamethylcyclotetrasiloxane (D4) in male and female rats following repeated nose-only vapor inhalation exposures
86. Variability of fine particle deposition in healthy adults: Effect of age and gender
87. Exercise increases sulfur dioxide-induced bronchoconstriction in asthmatic subjects
88. Effects of inhalation of acidic compounds on pulmonary function in allergic adolescent subjects
89. Effects of near ambient levels of sulfuric acid aerosol on lung function in exercising subjects with asthma and chronic obstructive pulmonary disease
90. The environment and the lung
91. Comparison of pulmonary responses of asthmatic and nonasthmatic subjects performing light exercise while exposed to a low level of ozone
92. Bronchoalveolar lavage neutrophilia in asthmatic and healthy volunteers after controlled exposure to ozone and filtered purified air
93. The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis
94. Sulfuric acid aerosol followed by ozone exposure in healthy and asthmatic subjects
95. Responses of subjects with chronic obstructive pulmonary disease after exposures to 0.3 ppm ozone
96. Pulmonary performance of elderly normal subjects and subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen dioxide
97. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease
98. A technique to expose animals to concentrated fine ambient aerosols
99. Pulmonary and cardiovascular effects of acute exposure to concentrated ambient particulate matter in rats
100. Healthy volunteers demonstrate no lung inflammation after exposure to fine particles concentrated from Chapel Hill ambient air
101. Pulmonary function responses after inhalation of controlled levels of concentrated urban particles in healthy individuals
102. Increased pulmonary toxicity of inhaled ultrafine particles: Due to lung overload alone?
103. Diesel exhaust: A critical analysis of emissions, exposure and health effects
104. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern
105. Environmental tobacco smoke and asthma in adults
106. Airway and cardiovascular effects of inhaled ultrafine carbon particles in resting, healthy, nonsmoking adults
107. Effects of ozone exposure in Canadians and Southern Californians. Evidence for adaptation?